Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis is a research paper published in Cell Death and Disease (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: 1R01CA240818-01A1
Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy
U.S. Department of Defense
Grant: W81XWH-20-1-0625
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R01DK123079-01
Unraveling the Role of NADPH Oxidase in Inflammation-associated Pancreatic Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R56DK123079-01
SUNY | Stony Brook University
Grant: SUNY Central Award
SUNY | Stony Brook University
Grant: DoM Pilot Project Award
SUNY | Stony Brook University
Grant: Start-up Fund
National Natural Science Foundation of China
Grant: 81270540
National Natural Science Foundation of China
Grant: 81670585
NIDDK NIH HHS
Grant: R56 DK123079
NCI NIH HHS
Grant: R01 CA240818
NIDDK NIH HHS
Grant: R01 DK123079
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
FWCI
0.51
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals